Once the pricing of several large EU markets are known, I expect a peak revenue estimate to be at least $1B for all of the EU. Rest of world, including USA, another $1B peak. Takeout at 3x $2B peak revs. $12
Note, according to a note from the II #1 biotech analyst from Evercore ISI, Umer Raffat, PFE paid about 4x his peak revenue estimate for Monday’s deal.